drugset / Trial / NCT02062658

Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

NCT02062658 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.

Timeline

Start
2013-12
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous